Dilated cardiomyopathy: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• DMD 0
• SGLT2 0
• TP53 0
• IL-1 1
• IL-17 0
• NRF2 0
• PI3K 0
• PPAR 0
• CD40 0
• ERK 0
• GLP-1 0
• IL-6 0
• MAPK 0
• mTOR 0
• NLRP3 0
• PD-1 0
• PDE4 0
• PINK1 0
• RUNX1 0
• STAT3 0
• STING 0

660 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAMS · R21

  Failure to resolve an adaptive stress state contributes to Duchenne Muscular Dystrophy Severity

  University of Southern California· Los Angeles, Egyesült Államok· 211 650 USD awarded in fiscal year 2026· until 2028. aug.

• NIH NIA · R44

  IND-enabling program for novel stimulant FBD-400

  Firebird Pharmaceuticals, Inc.· Boston, Egyesült Államok· 1 654 275 USD awarded in fiscal year 2026· until 2028. máj.

• NIH NINDS · R56

  Treg-mediated tolerance of dystrophin immunity

  University of California-Irvine· Irvine, Egyesült Államok· 549 500 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIAMS · R01

  Targeting protein N-terminal methyltransferase in muscle diseases

  Purdue University· West Lafayette, Egyesült Államok· 587 757 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIAMS · R21

  Lipin1 and Micro-Dystrophin Gene Therapies for DMD: Independent and Combined Therapeutic Potential

  Wright State University· Dayton, Egyesült Államok· 377 077 USD awarded in fiscal year 2026· until 2028. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  From n=1 to many: Scaling-up gene editing for future heart therapies (ONE2MANY)

  Klinikum Der Technischen Universität München (Tum Klinikum)· Muenchen, Németország· EU contribution 1 499 468 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Arrhythmogenesis in Dilated Cardiomyopathy: Role of Mechano-Electric Coupling (RhythMEC)

  Albert-Ludwigs-Universitaet Freiburg· Freiburg, Németország· EU contribution 265 648 EUR· until 2028. aug.· 2 countries

• European Commission (Horizon Europe) · HORIZON-EIC

  Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions (CARDIOREPAIR)

  European Molecular Biology Laboratory· Heidelberg, Németország· EU contribution 4 617 351 EUR· until 2028. szept.· 2 countries

• European Commission (Horizon Europe) · HORIZON-EIC

  Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families. (DCM-NEXT)

  Stichting Amsterdam Umc· Amsterdam, Hollandia· EU contribution 4 137 669 EUR· until 2027. szept.· 5 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  Beyond the chromosome: unravelling the interplay between inter-chromosomal genome architecture and mRNA biogenesis (TRANS-3)

  Universita Degli Studi di Torino· Torino, Olaszország· EU contribution 1 769 998 EUR· until 2028. aug.

10 of 275 running projects, newest first. Listed amounts together: 147,8 M USD + 14,8 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Felfüggesztve

  Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

  NCT04331769· Ancora Heart, Inc.· Frissítve: 2026. jún. 3.

  “Recruitment on hold pending modifications to the clinical investigation plan”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities

  NCT04572893· Bristol-Myers Squibb· Frissítve: 2025. máj. 21.

  “Business objectives have changed”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  New Horizons for the Treatment of Cardiomyopathy in Children

  NCT04893629· Damascus University· Frissítve: 2025. febr. 20.

  “lack of necessary equipment”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Ventricular Sling for Heart Failure With Reduced Ejection Fraction

  NCT04475315· University of Miami· Frissítve: 2022. máj. 11.

  “Difficulty with recruitment”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling

  NCT06356727· Azienda Ospedaliera Universitaria Integrata Verona· Forrás

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Forrás

• Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

  NCT07646600· AstraZeneca· Forrás

• A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy

  NCT07241104· AstraZeneca· Forrás

• ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

  NCT07218887· Alexion Pharmaceuticals, Inc.· Forrás

• A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

  NCT06464588· Emory University· Forrás

• A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

  NCT05981092· Alexion Pharmaceuticals, Inc.· Forrás

• AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  NCT06699056· Peerbridge Health, Inc· Forrás

• Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy

  NCT03843255· Imperial College London· Forrás

• UIC Multi-Ethnic DCM Registry

  NCT07145138· University of Illinois Chicago· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 7
• Organoids 1
• Mendelian Randomization Analysis 8
• CRISPR-Cas Systems 2
• Gene Expression Profiling 23
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 11
• Proteomics 9
• Metabolomics 3
• Immunohistochemistry 3
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 20
• Machine Learning 8
• Deep Learning 2
• Cohort Studies 15
• Genome-Wide Association Study 11

• Arrhythmic Risk Stratification in Non-Ischaemic Cardiomyopathy: The Role of Cardiac Magnetic Resonance Imaging.

  Curr Cardiol Rep, 2026. okt.

• Case 351: Thalamic Dementia Secondary to Dural Arteriovenous Fistula.

  Radiology, 2026. okt.

• Acute psychosis unmasking severe non-ischaemic cardiomyopathy with biventricular thrombosis and cardioembolic cerebral infarcts.

  BMJ Case Rep, 2026. szept.

• [Incremental value of CMR for the 2025 appropriate use criteria of ICD implantation in sudden cardiac death risk stratification of dilated cardiomyopathy].

  Zhonghua Xin Xue Guan Bing Za Zhi, 2026. jún.

• Hybrid Cardiac 68Ga-FAPI-4 PET/MRI in Dilated Cardiomyopathy: A Feasibility and Pilot Study.

  Radiology, 2026. jún.

• Cardiac magnetic resonance-derived atrioventricular coupling index for predicting left ventricular reverse remodeling in dilated cardiomyopathy.

  Clin Radiol, 2026. ápr.

• Large Language Models for Cardiac MRI Diagnosis Based on Standardized Text Descriptions.

  J Magn Reson Imaging, 2026. ápr.

• Midwall Late Gadolinium Enhancement and Native T1 Elevation in Chronic Myocarditis-Related Dilated Cardiomyopathy: An Evidence-Based Case Report.

  Acta Med Indones, 2026. ápr.

• Prognostic value of cardiac magnetic resonance-derived global longitudinal strain in LGE-negative dilated cardiomyopathy.

  PLoS One, 2026. márc.

• Meta-analysis of the role of cardiac magnetic resonance in laminopathy.

  Arch Cardiovasc Dis, 2026. márc.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.